Skip to Main Content

WASHINGTON — Drug and device companies with manufacturing operations in Puerto Rico have told the American public that their plants are getting up and running again, but that does “not reveal the true scope of the challenge that we are facing,” Food and Drug Administration Commissioner Scott Gottlieb said in prepared congressional testimony made available Monday.

“We have surveyed firms and can anecdotally relate that reports of manufacturing running below 50 percent are common, with many firms operating around 20 percent capacity, and some even less,” Gottlieb’s remarks read. “We have found no firm operating above 70 percent of their normal operation.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!